|Original language||English (US)|
|Number of pages||3|
|Journal||JAMA - Journal of the American Medical Association|
|State||Published - Aug 13 2019|
ASJC Scopus subject areas
Access to Document
Other files and links
Perceived bullying among internal medicine residents. / Ayyala, Manasa S.; Rios, Rebeca E; Wright, Scott M.In: JAMA - Journal of the American Medical Association, Vol. 322, No. 6, 13.08.2019, p. 576-578.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Perceived bullying among internal medicine residents
AU - Ayyala, Manasa S.
AU - Rios, Rebeca E
AU - Wright, Scott M.
N1 - Funding Information: Funding/Support: Dr Bikdeli was supported by grant T32 HL007854 from the NHLBI. Funding Information: Conflict of Interest Disclosures: Dr Bikdeli reported receiving grants from the National Heart, Lung, and Blood Institute (NHLBI) and having served as a consulting expert (on behalf of the plaintiff) for litigation related to a specific type of inferior vena cava (IVC) filter. Dr Jimenez reported receiving personal fees from Bayer, Bristol-Myers Squibb, Daiichi Sankyo, LEO Pharma, Pfizer, and Sanofi-Aventis. Dr Monreal reported receiving grants from Sanofi and Bayer. Dr Goldhaber reported receiving grants from Janssen, Portola, Bristol-Myers Squibb, and Daiichi Sankyo and personal fees from Boehringer Ingelheim. Dr Krumholz reported that he has served as an expert witness (on behalf of the plaintiff) for litigation related to a specific type of IVC; received a research grant through Yale from Medtronic and the US Food and Drug Administration; is a recipient of a research agreement with Medtronic and Johnson & Johnson (Janssen) through Yale; works under contract with the Centers for Medicare & Medicaid Services; chairs a cardiac scientific advisory board for UnitedHealth; is a participant and participant representative of IBM Watson Health; serves on the board of Life Sciences and on the advisory boards of Element Science and Aetna; and is the founder of Hugo. No other disclosures were reported.
PY - 2019/8/13
Y1 - 2019/8/13
UR - http://www.scopus.com/inward/record.url?scp=85070511765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070511765&partnerID=8YFLogxK
U2 - 10.1001/jama.2019.8616
DO - 10.1001/jama.2019.8616
M3 - Letter
C2 - 31408125
AN - SCOPUS:85070511765
VL - 322
SP - 576
EP - 578
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0098-7484
IS - 6